Deutsche Bank’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-20,068
Closed -$97.9K 3621
2025
Q1
$97.9K Buy
20,068
+5
+0% +$30 ﹤0.01% 3201
2024
Q4
$167K Buy
20,063
+15,465
+336% +$135K ﹤0.01% 3144
2024
Q3
$47.8K Sell
4,598
-54,081
-92% -$899K ﹤0.01% 3371
2024
Q2
$1.15M Buy
58,679
+22,162
+61% +$444K ﹤0.01% 1919
2024
Q1
$935K Buy
36,517
+1,720
+5% +$44.1K ﹤0.01% 2050
2023
Q4
$960K Buy
34,797
+153
+0.4% +$9.33K ﹤0.01% 2050
2023
Q3
$2.11M Buy
34,644
+15,484
+81% +$1.09M ﹤0.01% 1335
2023
Q2
$1.26M Buy
19,160
+8,665
+83% +$634K ﹤0.01% 1856
2023
Q1
$667K Buy
10,495
+1,206
+13% +$138K ﹤0.01% 2329
2022
Q4
$1.29M Buy
9,289
+7,715
+490% +$1.09M ﹤0.01% 1891
2022
Q3
$199K Sell
1,574
-92
-6% -$10.4K ﹤0.01% 2950
2022
Q2
$138K Sell
1,666
-443
-21% -$34.4K ﹤0.01% 3361
2022
Q1
$204K Sell
2,109
-206
-9% -$27.2K ﹤0.01% 3252
2021
Q4
$462K Sell
2,315
-5,771
-71% -$1.36M ﹤0.01% 2899
2021
Q3
$2M Buy
8,086
+3,622
+81% +$1.04M ﹤0.01% 2104
2021
Q2
$1.85M Buy
4,464
+1,920
+75% +$761K ﹤0.01% 2304
2021
Q1
$994K Sell
2,544
-5,976
-70% -$2.94M ﹤0.01% 2660
2020
Q4
$4.77M Sell
8,520
-16,086
-65% -$10.2M ﹤0.01% 1389
2020
Q3
$17.2M Sell
24,606
-1,004
-4% -$783K 0.01% 755
2020
Q2
$20.3M Sell
25,610
-3,890
-13% -$2.93M 0.02% 695
2020
Q1
$17.6M Buy
29,500
+4,167
+16% +$4.06M 0.02% 692
2019
Q4
$28.8M Buy
25,333
+3,032
+14% +$3.3M 0.02% 649
2019
Q3
$26.5M Sell
22,301
-1,466
-6% -$2.24M 0.02% 675
2019
Q2
$39.2M Buy
23,767
+2,514
+12% +$4.35M 0.02% 672
2019
Q1
$43.3M Buy
21,253
+589
+3% +$1.04M 0.03% 632
2018
Q4
$26.6M Buy
20,664
+492
+2% +$755K 0.02% 743
2018
Q3
$38.1M Sell
20,172
-251
-1% -$519K 0.02% 778
2018
Q2
$41.5M Sell
20,423
-9,405
-32% -$21.4M 0.02% 748
2018
Q1
$66M Buy
29,828
+1,738
+6% +$4.42M 0.03% 532
2017
Q4
$64.8M Buy
28,090
+8,164
+41% +$16.6M 0.04% 451
2017
Q3
$35.4M Buy
19,926
+22
+0.1% +$30.7K 0.02% 693
2017
Q2
$27.1M Sell
19,904
-3,357
-14% -$4.05M 0.02% 782
2017
Q1
$27.4M Sell
23,261
-729
-3% -$744K 0.02% 743
2016
Q4
$19.2M Sell
23,990
-5,509
-19% -$4.37M 0.02% 892
2016
Q3
$25.9M Sell
29,499
-4,452
-13% -$3.22M 0.02% 790
2016
Q2
$19M Buy
33,951
+5,449
+19% +$3.09M 0.01% 944
2016
Q1
$15.7M Sell
28,502
-4,667
-14% -$2.87M 0.01% 1017
2015
Q4
$27.6M Buy
33,169
+4,426
+15% +$4.42M 0.02% 790
2015
Q3
$31.8M Sell
28,743
-11,119
-28% -$20.3M 0.02% 653
2015
Q2
$86.9M Buy
39,862
+29,899
+300% +$60.9M 0.06% 393
2015
Q1
$15.6M Sell
9,963
-1,280
-11% -$1.69M 0.01% 1070
2014
Q4
$13.4M Sell
11,243
-41
-0.4% -$27.4K 0.01% 1243
2014
Q3
$5.24M Buy
11,284
+3,129
+38% +$1.44M ﹤0.01% 1793
2014
Q2
$4.07M Sell
8,155
-339
-4% -$109K ﹤0.01% 1964
2014
Q1
$2.5M Buy
8,494
+7,260
+588% +$2.2M ﹤0.01% 2262
2013
Q4
$335K Sell
1,234
-1,465
-54% -$409K ﹤0.01% 3371
2013
Q3
$942K Buy
+2,699
New +$1M ﹤0.01% 3018

Other funds holding BLUE

Deutsche Bank's BLUE Position: Q2 2025 in Review

Deutsche Bank sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 20,068 shares — an estimated $97.9K sold.

Deutsche Bank first reported a position in BLUE in Q3 2013 and held it in 47 quarters. The position peaked at $86.9M in Q2 2015. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

  • Deutsche Bank reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
  • Deutsche Bank sold 20,068 bluebird bio shares in Q2 2025, an estimated $97.9K.
  • Deutsche Bank first reported a position in bluebird bio in Q3 2013 and held it in 47 quarters.
  • Deutsche Bank's bluebird bio position peaked at $86.9M in Q2 2015.
  • 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Deutsche Bank's 13F filing for Q2 2025, filed 12 Aug 2025.